Nuon Therapeutics, Inc. brings together global thought leaders in both autoimmune disease and inflammation. Both Marc Feldmann and Larry Steinman have extensive experience in the scientific investigation of autoimmune diseases, clinical development of new drugs and commercialization of new therapies. Together with Nuon’s Founder Michael Selley, Professors Feldmann and Steinman are Co-Founders, and also investors and shareholders of Nuon Therapeutics, Inc.
Tito Serafini, Ph.D. – Chief Scientific Officer – (Chair)
- Co-Founder and Vice President, Renovis, Inc.
- Faculty, Department of Molecular and Cell Biology, UC Berkeley
- Postdoctoral fellowship, UCSF
- Ph.D. in Biochemistry, Stanford
Professor Marc Feldmann, M.B., B.S., Ph.D., FRCPath, FRCP, FMedSci, FAA, FRS
- Head, Kennedy Institute of Rheumatology, Faculty of Medicine, Imperial College London
- Professor of Cellular Immunology, University of London
- Co-Inventor of anti-TNF alpha therapeutic class
- Albert Lasker Award for Clinical Medical Research, 2003
- Crafoord Prize of the Royal Swedish Academy, 2000, for anti-TNF therapy
- Nuon Co-Founder, Investor and Shareholder
Michael Kitt, M.D. - Chief Medical Officer
- Senior Vice President, Development, Theravance Inc.
- Vice President, Clinical Research, COR Therapeutics
- Senior Vice President, Clinical Research, Sterling Winthrop
- Vice President, International Clinical Research, the Upjohn Company
Michael Selley, Ph.D.
- Previously Chief of Staff to the Australian Minister for Science and Technology
- Previously academic appointments at the John Curtin School of Medical Research, Australian National University conducting research on the molecular basis of cardiovascular diseases
- Nuon Founder, Investor and Shareholder
Professor Larry Steinman, B.A., M.D.
- Professor, Departments of Neurology and Neurological Sciences, Stanford University
- MD Harvard University, 1968-1973
- NIH Fellow at Harvard Medical School, 1970-1971, Senator Jacob Javits Neuroscience Investigator Award, Congress of the United States and NIH
- Co-Inventor of leading MS drug Tysabri
- Nuon Co-Founder, Investor and Shareholder